Gleevec: A New Therapeutic for Type I Diabetes?

Saved in:
Bibliographic Details
Published in:Clinical immunology (Orlando, Fla.) Fla.), 2007-01, Vol.123, p.S28-S28
Main Authors: Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA, Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA, Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA, Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA, Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA
Format: Article
Language:English
Subjects:
Allergy and Immunology
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page S28
container_issue
container_start_page S28
container_title Clinical immunology (Orlando, Fla.)
container_volume 123
creator Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA
Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA
Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA
Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA
Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA
description
doi_str_mv 10.1016/j.clim.2007.03.249
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_19679236</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1521661607006675</els_id><sourcerecordid>19679236</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1826-2911d91213d4e10ad8b58194a56d74ee302dfbf69202e16063c6f987acc23d263</originalsourceid><addsrcrecordid>eNp9kMFOg0AQQInRxFr9AU-cvEFndmEBYzRN1dqk0YP1vNkuQ1ykUHehpn8vpD158DRzeG-SeZ53jRAioJiUoa7MJmQASQg8ZFF24o0wZhgkwOPT4y4EinPvwrkSAGLGxMibzCuiHelbf-q_0o-_-iSrttS1RvtFY_3Vfkv-wn80ak0tuYdL76xQlaOr4xx7H89Pq9lLsHybL2bTZaAxZSJgGWKeIUOeR4Sg8nQdp5hFKhZ5EhFxYHmxLkTGgBEKEFyLIksTpTXjORN87N0c7m5t892Ra-XGOE1VpWpqOicxE0nG-ACyA6ht45ylQm6t2Si7lwhyaCNLObSRQxsJXPZteunuIFH_ws6QlU4bqjXlxpJuZd6Y__X7P3qP1Ear6ov25Mqms3UfR6J0TIJ8H-IP7SEBECKJ-S-XMH7M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>19679236</pqid></control><display><type>article</type><title>Gleevec: A New Therapeutic for Type I Diabetes?</title><source>ScienceDirect Freedom Collection</source><creator>Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA ; Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA</creator><creatorcontrib>Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA ; Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><identifier>ISSN: 1521-6616</identifier><identifier>EISSN: 1521-7035</identifier><identifier>DOI: 10.1016/j.clim.2007.03.249</identifier><language>eng</language><publisher>Elsevier Inc</publisher><subject>Allergy and Immunology</subject><ispartof>Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S28-S28</ispartof><rights>2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids></links><search><creatorcontrib>Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><creatorcontrib>Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA</creatorcontrib><creatorcontrib>Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><creatorcontrib>Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><creatorcontrib>Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><title>Gleevec: A New Therapeutic for Type I Diabetes?</title><title>Clinical immunology (Orlando, Fla.)</title><subject>Allergy and Immunology</subject><issn>1521-6616</issn><issn>1521-7035</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNp9kMFOg0AQQInRxFr9AU-cvEFndmEBYzRN1dqk0YP1vNkuQ1ykUHehpn8vpD158DRzeG-SeZ53jRAioJiUoa7MJmQASQg8ZFF24o0wZhgkwOPT4y4EinPvwrkSAGLGxMibzCuiHelbf-q_0o-_-iSrttS1RvtFY_3Vfkv-wn80ak0tuYdL76xQlaOr4xx7H89Pq9lLsHybL2bTZaAxZSJgGWKeIUOeR4Sg8nQdp5hFKhZ5EhFxYHmxLkTGgBEKEFyLIksTpTXjORN87N0c7m5t892Ra-XGOE1VpWpqOicxE0nG-ACyA6ht45ylQm6t2Si7lwhyaCNLObSRQxsJXPZteunuIFH_ws6QlU4bqjXlxpJuZd6Y__X7P3qP1Ear6ov25Mqms3UfR6J0TIJ8H-IP7SEBECKJ-S-XMH7M</recordid><startdate>20070101</startdate><enddate>20070101</enddate><creator>Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA</creator><creator>Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA</creator><creator>Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA</creator><creator>Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA</creator><creator>Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20070101</creationdate><title>Gleevec: A New Therapeutic for Type I Diabetes?</title><author>Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA ; Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA ; Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1826-2911d91213d4e10ad8b58194a56d74ee302dfbf69202e16063c6f987acc23d263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Allergy and Immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><creatorcontrib>Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA</creatorcontrib><creatorcontrib>Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><creatorcontrib>Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><creatorcontrib>Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA</creatorcontrib><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Clinical immunology (Orlando, Fla.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Louvet, Cedric, Postdoctoral Research Fellow, Diabetes Center at University of California, San Francisco, San Francisco, CA</au><au>Szot, Gregory L., Islet Transplant Facility Manager, Diabetes Center, San Francisco, CA</au><au>Lang, Jiena, Staff Research Associate, Diabetes Center at University of California, San Francisco, San Francisco, CA</au><au>Bluestone, Jeffrey A., Diabetes Center Director, Diabetes Center at University of California, San Francisco, San Francisco, CA</au><au>Lee, Michael R., Staff Research Assistant, Diabetes Center at University of California, San Francisco, San Francisco, CA</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gleevec: A New Therapeutic for Type I Diabetes?</atitle><jtitle>Clinical immunology (Orlando, Fla.)</jtitle><date>2007-01-01</date><risdate>2007</risdate><volume>123</volume><spage>S28</spage><epage>S28</epage><pages>S28-S28</pages><issn>1521-6616</issn><eissn>1521-7035</eissn><pub>Elsevier Inc</pub><doi>10.1016/j.clim.2007.03.249</doi></addata></record>
fulltext fulltext
identifier ISSN: 1521-6616
ispartof Clinical immunology (Orlando, Fla.), 2007-01, Vol.123, p.S28-S28
issn 1521-6616
1521-7035
language eng
recordid cdi_proquest_miscellaneous_19679236
source ScienceDirect Freedom Collection
subjects Allergy and Immunology
title Gleevec: A New Therapeutic for Type I Diabetes?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T18%3A30%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gleevec:%20A%20New%20Therapeutic%20for%20Type%20I%20Diabetes?&rft.jtitle=Clinical%20immunology%20(Orlando,%20Fla.)&rft.au=Louvet,%20Cedric,%20Postdoctoral%20Research%20Fellow,%20Diabetes%20Center%20at%20University%20of%20California,%20San%20Francisco,%20San%20Francisco,%20CA&rft.date=2007-01-01&rft.volume=123&rft.spage=S28&rft.epage=S28&rft.pages=S28-S28&rft.issn=1521-6616&rft.eissn=1521-7035&rft_id=info:doi/10.1016/j.clim.2007.03.249&rft_dat=%3Cproquest_cross%3E19679236%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1826-2911d91213d4e10ad8b58194a56d74ee302dfbf69202e16063c6f987acc23d263%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=19679236&rft_id=info:pmid/&rfr_iscdi=true